InvestorsHub Logo
Followers 45
Posts 3398
Boards Moderated 0
Alias Born 12/07/2003

Re: None

Friday, 09/12/2014 2:35:51 AM

Friday, September 12, 2014 2:35:51 AM

Post# of 3402
Odyssey Marine Exploration and Morphogenesis discover biotech 'treasures' in the deep

I can't give this much weight so far as to how this will benefit Odyssey in the future financially because there are too many unknowns.Please follow my thinking on this if anyone has any opinions about it ,would be interested in hearing any theories.(See Comments below article)

"Researchers at biotech firm Morphogenesis have identified marine microorganisms that will yield critical pharmaceuticals such as anti-cancer drugs and antibiotics from seafloor sediment samples harvested by Odyssey"

................................

TAMPA, Fla., Sept. 11, 2014 /PRNewswire/ -- Morphogenesis Inc., a leading biotechnology and cancer-treatment research and development firm, has discovered substances with pharmaceutical properties beneficial to mankind from seafloor sediment samples that were recovered from the ocean bottom by Odyssey Marine Exploration, Inc. and Recovery Limited Partnership.

"Equally as exciting as the discovery of Gold Rush-era treasure is the rich source of pharmaceutical treasure that can be uncovered," commented Michael J.P. Lawman, PhD., president and co-founder of Tampa-based Morphogenesis Inc.

Dr. Lawman and his group have analyzed deep-ocean sand, mud and rock samples recovered from wreck sites by the renowned undersea exploration company, Odyssey Marine Exploration, and are in the process of identifying bacterial isolates and studying them for potential drugs that target cancer and infectious diseases in both human and animal bio-pharmaceutical fields.

"We are obviously thrilled with the successful recovery of gold and silver, but the sediment we are recovering and delivering to Morphogenesis could hold its own valuable treasure," said Melinda MacConnel, Odyssey executive vice president and general counsel. "We are proud to provide these samples to Morphogenesis as their research and advancements in treatments for cancer and other diseases are amazingly impressive."

"In the harsh, forbidding deep-ocean environment, organisms are constantly evolving their own defense mechanisms, metabolic pathways and propagative systems in order to survive," observed Dr. Lawman. "Their unique capability and highly-evolved processes applied to sustain life under enormous pressure in extreme darkness and temperatures hold many secrets to improving the health and quality of life for humans and animals alike."

Dr. Lawman, an internationally recognized biotechnology researcher, is co-inventor on more than 30 U.S. and worldwide patents and has an extensive peer-reviewed publication record.

The sediment samples provided to Morphogenesis this month were recovered by Odyssey from the SS Central America, a side-wheel steamship which sank in 7,200 feet of water during a hurricane 160 miles off South Carolina in September of 1857. Odyssey is currently conducting an archaeological excavation of the shipwreck site in conjunction with a larger science program under contract for the Receiver of Recovery Limited Partnership.

Seafloor sediment samples were also previously recovered from the ocean floor adjacent to the debris field around the wreck of the SS Republic, a Civil War-era side-wheel steamship that sank in 1,700 feet of water in a hurricane in October, 1865 and discovered by Odyssey in 2003.

"Our R&D program with Odyssey Marine Exploration is particularly exciting because the treasure trove of products to be discovered is virtually infinite and has an unlimited potential to improve the quality of life on earth," declared Dr. Lawman.

Dr. Lawman provided the following general points to emphasize the importance of this research and development.
•Marine biotechnology is a growing field that involves discovery and application of processes/products derived from marine organisms.
•Over 70% of the earth's surface is covered by oceans which contain 95% of the earth's biosphere and encompasses 34 of the 36 living phyla described so far.
•As of 2001, marine natural product chemists have determined the chemical structures of over 13,000 novel compounds with different natural products entering FDA sponsored clinical trials for cancers, infectious diseases, pain reduction and treatment of inflammatory diseases.
•Since the discovery of penicillin in 1929, more than 10,000 marine bacterial metabolites have been shown to have biological activity, and 100 of these are in use today as antibiotics and anti-cancer agents.
•In 2010, it was reported that the clinical pipeline included 13 marine-derived compounds that are in FDA Phase I, Phase II or Phase III clinical trials.
The preclinical pipeline continues to supply several hundred novel marine compounds every year.

SOURCE Morphogenesis Inc.

http://www.digitaljournal.com/pr/2182660

...................

If I'm not mistaken there has been no official PR put out by Odyssey on this.They do comment in the article.So,the question is would this be material information or not.I suspect not at this point or they would have put out an official company PR on it?

How could Odyssey monetize something like this?

Would Morph pay them to collect samples or pay them to pick up some needed "material" from the bottom of the sea?

If they did pay Odyssey what would the value be?

I suspect the next question would be why would they hire Odyssey other than some other company or get their own boat to retrieve deep sea materials needed if they had a scientific treatment breakthrough?

Also,has this company already paid Odyssey for work and is yet to be reported?

or

Did Odyssey do this for free to develop a "potential" future partner in this field?

When it comes to new cancer treating technologies I am not too impressed on time frames.Every biotech company takes months and years to develop good usable FDA approved vaccines .....would Odyssey somehow get a piece of the pie if and when this became viable? Biotech companies do increase in value gradually as milestones are met with the FDA etc. If Odyssey had an agreement to supply them with material from the sea and get a % of their future vaccine/cancer treatment sales it could give added value to the company.

Of course this is all complete speculation because we don't have enough information but could add increased value to the stock and just speculation alone could increase the share price slightly if people were given more information as to how Odyssey expects to monetize this.

The company Morphogenesis has some interesting research going on and looks like they are onto some cutting edge things so nothing is impossible here.

Important to note that in the article above it states "Odyssey Marine Exploration, Inc. and Recovery Limited Partnership"

Is this a sign of some future relationship with RLP who is involved on the current project?

All kinds of questions remain with little to no answers but I'd keep it in the back of your mind as a possible future arrangement or agreement or partnership.



As well this could be an exercise in futility and they are just giving up samples free gratas without any pay whatsoever and is more as a "good will" public relations maneuver of sorts for Odyssey....Like I said there is just not enough discussion or information to go on here given to us by Odyssey.Why waste time giving things away "for science" or so that some other company can profit from your findings and waste valuable shareholder dollars ,taking the time and effort to do these things of a charitable nature? I suspect there must be some kind of monetization plan on this or shareholders probably will be complaining of money wasted.When I do own the stock as I (come and go as I please),I certainly wouldn't want them to be giving this things up for free I'm not investing in a charity here.

Here is the companys website >>>>

http://www.morphogenesis-inc.com/

Here is a video you might want to watch which shows how progressive they are >>>>>

New vaccine helps pets with cancer

http://www.clickorlando.com/news/new-vaccine-helps-pets-with-cancer/22401344

IF nothing else it shows that Odyssey has no plans on failure as a company.They are "keeping the dream alive" so to speak by looking at everything that is available and everything that is monetizable at the bottom of the seas.I don't see them going out of business but as I stated previously they must in my opinion continue working on a monetizable project when this one is completed and DO NOT sit on their rearends all winter as every season ends and laziness seems to set in.I'm sorry if this offends anyone at Odyssey but you have to see it from our perspective.There is plenty of warm water in the world in winter months.Why aren't you there? If there are 3 million shipwrecks worldwide surely you can monetize "SOMETHING" during the winter months.If you can't then maybe your business model is not as viable as you portray?

My Posts are my opinion protected by my first amendment right to free speech


You don't drown by falling in the water; you drown by staying there.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OMEX News